CHRONIC HBV INFECTION

Clinical trials for CHRONIC HBV INFECTION explained in plain language.

Never miss a new study

Get alerted when new CHRONIC HBV INFECTION trials appear

Sign up with your email to follow new studies for CHRONIC HBV INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New hope for bleeding risk in hepatitis b patients?

Disease control Completed

This study tested the drug eltrombopag in 48 Chinese adults with chronic hepatitis B and a bleeding disorder called immune thrombocytopenia (low platelets). The goal was to see if taking eltrombopag for 6 to 22 weeks could safely raise platelet counts. The trial is complete, but …

Matched conditions: CHRONIC HBV INFECTION

Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Jun 27, 2026 09:05 UTC

CHRONIC HBV INFECTION

Get alerted when new CHRONIC HBV INFECTION trials appear

New hope for bleeding risk in hepatitis b patients?